Evidence map›Paper›PMID 36725934›Full record

ArticleNature2023

Single-cell spatial landscapes of the lung tumour immune microenvironment.

Mark Sorin, Morteza Rezanejad, Elham Karimi, Benoit Fiset, Lysanne Desharnais, Lucas J M Perus, Simon Milette, Miranda W Yu, Sarah M Maritan, Samuel Doré and 15 more

Open access · hybridAbstract read
In one paragraph

Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 245 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
245citing papers in PubMed, 2 pooled it
59.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

245 citing papers in PubMed, 2 syntheses or guidelines pooled it, 357 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Loss of NCCRP1 overcomes immune evasion in lung adenocarcinoma.Journal for immunotherapy of cancer · 2026
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  19. Review
  20. Review

185 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 1 country.

Mark Sorin *Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
Morteza Rezanejad *Department of Psychology, University of Toronto, Toronto, Ontario, Canada.
Elham Karimi *Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
Benoit FisetRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.ORCID 0000-0003-0372-8868
Lysanne DesharnaisRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
Lucas J M PerusRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
Simon MiletteRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
Miranda W YuRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.ORCID 0000-0003-3902-0124
Sarah M MaritanRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
Samuel DoréRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
Émilie PichetteFaculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
William EnlowInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Québec City, Quebec, Canada.ORCID 0000-0003-2990-9763
Andréanne GagnéInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Québec City, Quebec, Canada.ORCID 0000-0002-3833-4159
Yuhong WeiRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
Michele OrainInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Québec City, Quebec, Canada.
Venkata S K ManemInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Québec City, Quebec, Canada.
Roni RayesRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
Peter M SiegelRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.ORCID 0000-0002-5568-6586
Sophie Camilleri-BroëtDepartment of Pathology, McGill University, Montreal, Quebec, Canada.
Pierre Olivier FisetDepartment of Pathology, McGill University, Montreal, Quebec, Canada.
Patrice DesmeulesInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Québec City, Quebec, Canada.
Jonathan D SpicerRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
Daniela F QuailRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada. daniela.quail@mcgill.ca.ORCID 0000-0002-6969-3250
Philippe JoubertInstitut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Québec City, Quebec, Canada. philippe.joubert@criucpq.ulaval.ca.ORCID 0000-0001-7784-6387
Logan A WalshRosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada. logan.walsh@mcgill.ca.ORCID 0000-0001-8771-2577
McGill University · CAInstitut universitaire de cardiologie et de pneumologie de Québec · CAMcGill University Health Centre · CAInnovation and Economic Development Trois Rivières · CAMcGill Genome Centre · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-cell technologies have revealed the complexity of the tumour immune microenvironment with unparalleled resolution

Indexed as

Adenocarcinoma of LungLung NeoplasmsSingle-Cell AnalysisTumor MicroenvironmentCarcinoma, Non-Small-Cell LungDeep LearningDisease ProgressionHumansLungPrognosis

Identifiers

PMID36725934
PMCPMC9931585
OpenAlexW4318831792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.